Which treatment best induces remission during an acute myasthenia gravis flare: plasma exchange (plasmapheresis) or intravenous immunoglobulin (IVIG)?

Treatment for Acute Myasthenia Gravis Crisis

Both plasma exchange (plasmapheresis) and IVIG are equally effective for inducing remission during acute myasthenia gravis flares, but plasma exchange provides faster clinical improvement in the first 1-2 weeks, which may be critical in myasthenic crisis.

Primary Treatment Options

The two evidence-based treatments for acute MG exacerbations are:

• Plasma Exchange (PLEX): 200-250 mL plasma/kg body weight over 5 sessions
• Intravenous Immunoglobulin (IVIG): 0.4 g/kg body weight daily for 5 days (total 2 g/kg)

Evidence-Based Treatment Selection

When to Favor Plasma Exchange

PLEX demonstrates superior early response in the critical first two weeks:

• Significantly shorter ICU stay length 1
• Better ventilatory status at 2 weeks 2
• Earlier improvement in quantitative myasthenia gravis scores (QMG), manual muscle testing (MMT), and activities of daily living (ADL) at one week off ventilation 1
• Trend toward faster efficacy with mean difference of -2.8 in QMG score change (though not statistically significant) 3
• Higher overall response rate in acute MG patients 4

When to Favor IVIG

IVIG offers practical advantages with comparable long-term outcomes:

• Easier to administer and more widely available 5
• Shorter hospital stays overall 6
• Lower complication rates, particularly fewer severe complications 6
• Significantly reduced anti-AChR antibody titers 1
• Better tolerated in children and pregnant women 5
• Fewer procedural complications (5 episodes vs 13 with PLEX) 2

Clinical Outcomes at One Month

Both treatments achieve equivalent efficacy by one month 1, 7:

• 93-96% of patients achieve improvement of ≥2 grades in MG Foundation of America classification
• No significant difference in mortality between treatments 4
• Similar functional outcomes at 1 month 2

Treatment Algorithm

For Myasthenic Crisis (respiratory failure requiring ventilation):

• First choice: Plasma Exchange - prioritize faster improvement to reduce ventilator days and ICU stay
• Monitor for complications: hemodynamic instability, line infections, hemoglobin drop

For Severe Worsening Without Crisis:

• Either PLEX or IVIG acceptable - base decision on:
  • Local availability and expertise
  • Vascular access quality
  • Patient comorbidities
  • Previous treatment response

For Pregnant Women:

• Prefer IVIG - neither is contraindicated, but PLEX requires additional monitoring 5

For Children:

• Prefer IVIG - better tolerated, fewer complications 5

Important Caveats

Combination Therapy Not Recommended

PLEX followed by IVIG is no more effective than either treatment alone 5

Ineffective Treatments

• Corticosteroids alone: Eight RCTs showed no benefit in acute treatment; oral corticosteroids had negative effects 5
• Methotrexate: Not indicated for acute crisis management
• Protamine: Not a treatment for myasthenia gravis

Common Pitfalls

• Hemoglobin monitoring: Both treatments cause significant hemoglobin drops 1
• Acetylcholinesterase inhibitor dosing: Patients receiving rescue therapy require lower doses at one month 7
• Antibody titers: IVIG more effectively reduces anti-AChR antibodies, but clinical significance unclear 1

Adverse Events

Both treatments have comparable overall safety profiles 5, 4, though:

• PLEX: Higher rate of severe complications (line infections, hemodynamic instability)
• IVIG: Risk of renal failure, thrombosis, aseptic meningitis, hemolysis 8

Real-World Considerations

In resource-limited settings where neither PLEX nor IVIG is available, standard care alone (acetylcholinesterase inhibitors and immunosuppression optimization) still results in 90.5% improvement rate, though requiring higher medication doses 7. However, this should not discourage use of rescue therapy when available, given the faster improvement and reduced ICU burden with PLEX.